<p><b>A</b>) PCSK9 transfection. HEK293 cells were transfected with PCSK9-V5 or empty control pIRES-V5 vector prior to being lysed in 1x RIPA. LDLR and LRP-1 levels were examined by Western blot in these cells, as well as in HepG2 cells stably expressing PCSK9-shRNA. PCSK9 levels were assessed using mAb-V5 in HEK293 cells and an anti-PCSK9 antibody in HepG2 cells. The levels of LDLR and LRP-1 were estimated relative to β-actin. Data are representative of at least three independent experiments. <b>B</b>) PCSK9 media swap. Conditioned serum-free media collected from HEK293 cells transfected with PCSK9-V5 or empty control pIRES-V5 vector was collected and applied to naive HEK293 or HepG2 cells. The effect of exogenous PCSK9 on LDLR and LRP-1 w...
<p>(A) Western blot of liver lysates taken from negative siRNA or APLP2 siRNA treated mice showing r...
PCSK9 is a secreted ligand and negative post-translational regulator of low-density lipoprotein rece...
Proprotein convertase subtilisin kexin 9 (PCSK9) increases LDL cholesterol (C) concentration by acce...
<p><b>A</b>) Chimeric PCSK9 constructs. Schematic representation of PCSK9 and its CHRD coupled to th...
<p><b>A</b>) LDLR and LRP-1 are differentially regulated in B16F1 and B16F10 cells. The expression l...
<p>(A-B) HepG2 cells were transfected without (Empty) or with V5-tagged PCSK9 full-length (FL), ΔCTD...
<p><b>A</b>) Generation of chimeric truncated LDLR-V5 constructs. Schematic representation of the LD...
<p>(A and B) Western blot showing APLP2, PCSK9, or Transferrin receptor (TFNR) levels in input fract...
BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) post-transcriptionally degrades th...
<p>(A) HepG2 cells transfected with LDLR-EGFP were incubated 5h with conditioned media obtained from...
<p><b>A</b>) and <b>C</b>) Secreted Fc (human IgG1 fragment crystallizable region), Fcpro (Fc fused ...
<p>(A) PCSK9 further reduced LPS uptake in Ldlr-/- cells. Primary hepatocytes were isolated from Ldl...
The discovery that proprotein convertase subtilisin/kexin type 9 (PCSK9) mediates degradation of low...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted glycoprotein regulating the degr...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes degradation of low-density lipoprotei...
<p>(A) Western blot of liver lysates taken from negative siRNA or APLP2 siRNA treated mice showing r...
PCSK9 is a secreted ligand and negative post-translational regulator of low-density lipoprotein rece...
Proprotein convertase subtilisin kexin 9 (PCSK9) increases LDL cholesterol (C) concentration by acce...
<p><b>A</b>) Chimeric PCSK9 constructs. Schematic representation of PCSK9 and its CHRD coupled to th...
<p><b>A</b>) LDLR and LRP-1 are differentially regulated in B16F1 and B16F10 cells. The expression l...
<p>(A-B) HepG2 cells were transfected without (Empty) or with V5-tagged PCSK9 full-length (FL), ΔCTD...
<p><b>A</b>) Generation of chimeric truncated LDLR-V5 constructs. Schematic representation of the LD...
<p>(A and B) Western blot showing APLP2, PCSK9, or Transferrin receptor (TFNR) levels in input fract...
BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) post-transcriptionally degrades th...
<p>(A) HepG2 cells transfected with LDLR-EGFP were incubated 5h with conditioned media obtained from...
<p><b>A</b>) and <b>C</b>) Secreted Fc (human IgG1 fragment crystallizable region), Fcpro (Fc fused ...
<p>(A) PCSK9 further reduced LPS uptake in Ldlr-/- cells. Primary hepatocytes were isolated from Ldl...
The discovery that proprotein convertase subtilisin/kexin type 9 (PCSK9) mediates degradation of low...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted glycoprotein regulating the degr...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes degradation of low-density lipoprotei...
<p>(A) Western blot of liver lysates taken from negative siRNA or APLP2 siRNA treated mice showing r...
PCSK9 is a secreted ligand and negative post-translational regulator of low-density lipoprotein rece...
Proprotein convertase subtilisin kexin 9 (PCSK9) increases LDL cholesterol (C) concentration by acce...